Cathepsin E as a potent anticancer protease

Tomoyo Kawakubo, Atsushi Yasukochi, Seiji Nakamura, Kenji Yamamoto

研究成果: ジャーナルへの寄稿総説査読

3 被引用数 (Scopus)


Cathepsin E (CatE), an endolysosomal aspartic protease, is predominantly expressed in cells of the immune system, and CatE-deficient mice exhibit phenotypes affecting immune responses; however, the precise role of this enzyme remains speculative. In this review, some of the knowledge obtained from a study of CatE functions in host defense against tumor cells is highlighted. In vivo studies using three different genotypes of syngeneic mice (CatE-deficent, wild-type and CatE-overexpressing transgenic mice) revealed that endogenous CatE expression levels are positively associated with the extent of tumor suppression. The number of apoptotic tumor cells and tumor-infiltrating activated macrophages increased in proportion to the endogenous CatE levels. In vitro studies also demonstrated the growth arrest and apoptosis of tumor cells by CatE without affecting normal cells through the proteolytic release of soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) from the cell surface. On the basis of these observations, the present review gives an account of the manifold functions of CatE in host defense against tumor cells.

ジャーナルjournal of oral biosciences
出版ステータス出版済み - 2011

!!!All Science Journal Classification (ASJC) codes

  • 医学(その他)
  • 生化学、遺伝学、分子生物学(全般)
  • 歯科学(全般)


「Cathepsin E as a potent anticancer protease」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。